Back to Journals » Drug Design, Development and Therapy » Volume 8

Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy

Total article views   Abstract views HTML views PDF downloads Totals
11,808 Dovepress* 10,727 701+ 1,006 11,428
PubMed Central* 0 380 126 380
Totals 10,727 1,081 1,132 11,808
*Since 21 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar